Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,975 | 203 | 96.7% |
| Education | $168.02 | 27 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $2,792 | 143 | $0 (2023) |
| AbbVie, Inc. | $404.79 | 14 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $404.67 | 14 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $384.73 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $263.38 | 9 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $260.26 | 13 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $163.31 | 4 | $0 (2024) |
| Genentech USA, Inc. | $65.90 | 3 | $0 (2021) |
| Scilex Pharmaceuticals Inc. | $61.31 | 1 | $0 (2019) |
| Amgen Inc. | $57.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $194.76 | 6 | Bayer Healthcare Pharmaceuticals Inc. ($163.31) |
| 2023 | $117.30 | 5 | Amarin Pharma Inc. ($117.30) |
| 2022 | $227.47 | 10 | Amarin Pharma Inc. ($227.47) |
| 2021 | $810.87 | 37 | Amarin Pharma Inc. ($789.87) |
| 2020 | $627.71 | 30 | Amarin Pharma Inc. ($582.81) |
| 2019 | $875.15 | 54 | Amarin Pharma Inc. ($272.73) |
| 2018 | $949.33 | 37 | Amarin Pharma Inc. ($436.47) |
| 2017 | $1,341 | 51 | Amarin Pharma Inc. ($365.53) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardio-renal | ||||||
| 09/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology | ||||||
| 06/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardio-renal | ||||||
| 03/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.31 | General |
| Category: Cardio-renal | ||||||
| 06/11/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardiovascular | ||||||
| 05/07/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiovascular | ||||||
| 04/02/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Cardiovascular | ||||||
| 03/05/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiovascular | ||||||
| 01/29/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Cardiovascular | ||||||
| 12/10/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiovascular | ||||||
| 11/05/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Cardiovascular | ||||||
| 10/08/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardiovascular | ||||||
| 09/03/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiovascular | ||||||
| 07/30/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardiovascular | ||||||
| 06/25/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Cardiovascular | ||||||
| 05/14/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardiovascular | ||||||
| 04/02/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardiovascular | ||||||
| 02/26/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiovascular | ||||||
| 01/22/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardiovascular | ||||||
| 12/11/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Cardiovascular | ||||||
| 12/04/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular | ||||||
| 11/13/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiovascular | ||||||
| 11/06/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 364 | 807 | $172,580 | $81,965 |
| 2022 | 5 | 456 | 1,011 | $200,780 | $104,454 |
| 2021 | 5 | 572 | 1,067 | $195,005 | $86,630 |
| 2020 | 7 | 967 | 1,528 | $212,960 | $56,188 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 642 | $135,090 | $58,556 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $22,960 | $15,902 | 69.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 16 | $5,600 | $4,256 | 76.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 47 | $8,930 | $3,252 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 768 | $148,700 | $72,295 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $17,820 | $12,826 | 72.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 121 | $21,010 | $9,128 | 43.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 30 | $10,500 | $8,004 | 76.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,750 | $2,200 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 272 | 750 | $127,500 | $40,247 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 140 | 140 | $30,995 | $22,568 | 72.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 149 | $28,310 | $17,645 | 62.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 16 | 16 | $4,000 | $3,247 | 81.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 12 | 12 | $4,200 | $2,924 | 69.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 319 | 775 | $131,750 | $39,569 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 149 | 170 | $32,300 | $5,603 | 17.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 60 | 61 | $4,575 | $3,689 | 80.6% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2020 | 260 | 341 | $30,690 | $2,641 | 8.6% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 71 | 71 | $5,325 | $2,447 | 46.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 60 | 61 | $2,440 | $1,275 | 52.2% |
| 99422 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes | Office | 2020 | 48 | 49 | $5,880 | $963.75 | 16.4% |
About Dr. Nhat Mai, M.D
Dr. Nhat Mai, M.D is a Family Medicine healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417023029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nhat Mai, M.D has received a total of $5,143 in payments from pharmaceutical and medical device companies, with $194.76 received in 2024. These payments were reported across 230 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,975).
As a Medicare-enrolled provider, Mai has provided services to 2,359 Medicare beneficiaries, totaling 4,413 services with total Medicare billing of $329,237. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Jose, CA
- Active Since 11/27/2006
- Last Updated 11/12/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417023029
Products in Payments
- Vascepa (Drug) $2,792
- INVOKANA (Drug) $260.26
- PRALUENT ALIROCUMAB INJECTION (Biological) $223.57
- PRALUENT (Biological) $181.10
- Kerendia (Drug) $163.31
- Creon (Drug) $155.11
- FARXIGA (Drug) $131.79
- JANUVIA (Drug) $129.72
- STEGLATRO (Drug) $124.99
- GARDASIL (Biological) $117.42
- BEVESPI AEROSPHERE (Drug) $89.65
- Xofluza (Drug) $65.90
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $61.31
- ELIQUIS (Drug) $55.13
- Prolia (Biological) $40.80
- JARDIANCE (Drug) $32.47
- QVAR (Drug) $27.66
- Amitiza (Drug) $24.56
- Livalo (Drug) $22.49
- BRILINTA (Drug) $21.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Jose
Milton Mccoll, M.d, M.D
Family Medicine — Payments: $4.9M
Donald Siao, Md, MD
Family Medicine — Payments: $22,670
Minh Thai, Md, MD
Family Medicine — Payments: $21,268
Dr. Linh Nguyen, D.o, D.O
Family Medicine — Payments: $18,110
Trung Nguyen, M.d, M.D
Family Medicine — Payments: $16,169
Dr. Shashwati Kale, M.d, M.D
Family Medicine — Payments: $11,410